Bassler Bonnie L

CIK 00016836074 companiesTARRYTOWN, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001683607

Recent Transactions

50 trades

Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2024-12-17+16,000→ 16,000 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2024-09-30$27.92/sh+1,342→ 59,796 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-08-15$1170.00/sh−756→ 1,382 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-08-15$371.40/sh+756→ 2,138 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-08-15−756→ 1,516 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-08-02$1115.00/sh−756→ 1,382 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-08-02−756→ 2,272 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-08-02$371.40/sh+756→ 2,138 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2024-07-18+2,125→ 2,125 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2024-06-28$26.80/sh+1,399→ 58,454 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-06-24$1062.00/sh−756→ 1,382 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-06-24$371.40/sh+756→ 2,138 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-06-24−756→ 3,028 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2024-06-07+9,293→ 57,055 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-06-05$380.95/sh+827→ 2,209 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-06-05−827→ 0 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-06-05$1011.00/sh−827→ 1,382 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2024-03-28$30.23/sh+1,240→ 47,762 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-02-26$979.25/sh−854→ 1,382 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-02-26−854→ 0 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-02-26$391.92/sh+854→ 2,236 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-01-30$380.95/sh+827→ 2,209 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-01-30−827→ 827 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-01-30$959.00/sh−827→ 1,382 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-01-03$380.95/sh+826→ 2,208 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-01-03$914.00/sh−826→ 1,382 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-01-03−826→ 1,654 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-01-02+135→ 1,382 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-01-02+1,607→ 1,607 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2023-12-29$27.71/sh+1,353→ 46,522 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2023-12-13−610→ 0 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-12-13$870.00/sh−610→ 1,247 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-12-13$376.69/sh+610→ 1,857 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2023-09-29$27.08/sh+1,384→ 45,169 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-08-21$391.92/sh+853→ 2,100 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-08-21$829.00/sh−853→ 1,247 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2023-08-21−853→ 854 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2023-08-10−853→ 1,707 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-08-10$789.00/sh−853→ 1,247 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-08-10$391.92/sh+853→ 2,100 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2023-06-30$31.03/sh+1,208→ 43,785 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2023-06-23+7,747→ 42,577 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2023-06-22+42,500→ 42,500 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2023-03-31$35.73/sh+1,049→ 34,830 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-03-24$818.00/sh−1,240→ 1,247 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-03-24$380.95/sh+1,240→ 2,487 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2023-03-24−1,240→ 2,480 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-02-03$380.95/sh+1,021→ 2,268 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-02-03$779.00/sh−1,021→ 1,247 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2023-02-03−1,021→ 3,720 total

Companies

Recent Filings

Address

777 OLD SAW MILL RIVER ROAD

TARRYTOWN, NY, 10591

View on SEC.gov